GABase from Pseudomonas fluorescens
SIGMA/G7509 - lyophilized powder, Protein ≥30 % by biuret
Synonym: GABase Enzyme; GABase from Pseudomonas; Pseudomonas GABase
MDL Number: MFCD00131113
Product Type: Chemical
| assay | ≥30 % (biuret) |
| biological source | Pseudomonas fluorescens |
| composition | Protein, ≥30% biuret |
| form | lyophilized powder |
| Quality Level | 200 ![]() |
| specific activity | ≥0.5 units/mg protein |
| storage temp. | −20°C |
| technique(s) | inhibition assay: suitable |
| Application: | GABase from Pseudomonas fluorescens has been used for GABase assay to quantify the extracellular and intracellular concentration of GABA (γ-aminobutyric acid). |
| Biochem/physiol Actions: | GABase catalyzes the conversion of γ-aminobutyric acid (GABA) to succinic acid in the central nervous system. It is used to measure GABA levels in various biological samples. p-Hydroxybenzaldehyde (HBA) is known to be a potential inhibitor on GABase. |
| General description: | Research area: Neuroscience GABase is a commercially available mixture composed of γ-aminobutyric acid aminotransferase (GABGT) and succinic semialdehyde dehydrogenase (SSDH) obtained from Pseudomonas fluorescens. |
| Other Notes: | One unit will convert 1.0 μmole of γ-aminobutyric acid (GABA) to succinic semialdehyde and then to succinate per min with a stoichiometric reduction of 1.0 μmole of NADP+ at pH 8.6 at 25 °C. |
| Packaging: | 10, 25 units in poly bottle |
| Physical form: | Partially purified lyophilized powder containing buffer salts and stabilizer |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥30 % (biuret) |
| activity | specific activity: ≥0.5 units/mg protein |
| Storage Temp. | −20°C |
| UNSPSC | 12352204 |

